Clinical Trial Update: Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing 3 months vs 6 months of Solaraze (diclofenac sodium 3% gel) for actinic keratosis on the face and head. The study assessed efficacy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Solaraze (diclofenac sodium)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Photosensitivity Disorders | Phase 4 | Status: COMPLETED